INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA • US4570301048

85.1 USD
+0.48 (+0.57%)
At close: Feb 27, 2026
85.106 USD
+0.01 (+0.01%)
After Hours: 2/27/2026, 8:11:05 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

IMKTA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 38 industry peers in the Consumer Staples Distribution & Retail industry. IMKTA has a great financial health rating, but its profitability evaluates not so good. IMKTA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year IMKTA was profitable.
  • IMKTA had a positive operating cash flow in the past year.
  • Each year in the past 5 years IMKTA has been profitable.
  • In the past 5 years IMKTA always reported a positive cash flow from operatings.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a Return On Assets value of 3.70%, IMKTA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • IMKTA's Return On Equity of 5.80% is on the low side compared to the rest of the industry. IMKTA is outperformed by 63.16% of its industry peers.
  • With a Return On Invested Capital value of 4.46%, IMKTA perfoms like the industry average, outperforming 42.11% of the companies in the same industry.
Industry RankSector Rank
ROA 3.7%
ROE 5.8%
ROIC 4.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • IMKTA has a Profit Margin of 1.76%. This is comparable to the rest of the industry: IMKTA outperforms 55.26% of its industry peers.
  • In the last couple of years the Profit Margin of IMKTA has declined.
  • With a Operating Margin value of 2.47%, IMKTA perfoms like the industry average, outperforming 55.26% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IMKTA has declined.
  • With a Gross Margin value of 24.13%, IMKTA perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IMKTA has declined.
Industry RankSector Rank
OM 2.47%
PM (TTM) 1.76%
GM 24.13%
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMKTA is destroying value.
  • There is no outstanding debt for IMKTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • IMKTA has an Altman-Z score of 4.53. This indicates that IMKTA is financially healthy and has little risk of bankruptcy at the moment.
  • IMKTA has a Altman-Z score of 4.53. This is in the better half of the industry: IMKTA outperforms 63.16% of its industry peers.
  • IMKTA has a debt to FCF ratio of 4.17. This is a neutral value as IMKTA would need 4.17 years to pay back of all of its debts.
  • IMKTA has a better Debt to FCF ratio (4.17) than 60.53% of its industry peers.
  • IMKTA has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.30, IMKTA is in the better half of the industry, outperforming 65.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.17
Altman-Z 4.53
ROIC/WACC0.54
WACC8.23%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 3.36 indicates that IMKTA has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.36, IMKTA belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
  • A Quick Ratio of 1.69 indicates that IMKTA should not have too much problems paying its short term obligations.
  • IMKTA's Quick ratio of 1.69 is amongst the best of the industry. IMKTA outperforms 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 3.36
Quick Ratio 1.69
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.98% over the past year.
  • The earnings per share for IMKTA have been decreasing by -12.98% on average. This is quite bad
  • The Revenue has decreased by -0.51% in the past year.
  • The Revenue has been growing slightly by 2.96% on average over the past years.
EPS 1Y (TTM)20.98%
EPS 3Y-32.58%
EPS 5Y-12.98%
EPS Q2Q%70.11%
Revenue 1Y (TTM)-0.51%
Revenue growth 3Y-2.07%
Revenue growth 5Y2.96%
Sales Q2Q%6.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2022 5 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.99, the valuation of IMKTA can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of IMKTA indicates a somewhat cheap valuation: IMKTA is cheaper than 68.42% of the companies listed in the same industry.
  • IMKTA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.10.
Industry RankSector Rank
PE 16.99
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • IMKTA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IMKTA is cheaper than 78.95% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMKTA indicates a rather cheap valuation: IMKTA is cheaper than 84.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.13
EV/EBITDA 6.87
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • IMKTA has a yearly dividend return of 0.76%, which is pretty low.
  • IMKTA's Dividend Yield is a higher than the industry average which is at 0.69.
  • With a Dividend Yield of 0.76, IMKTA pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

  • The dividend of IMKTA has a limited annual growth rate of 0.12%.
  • IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
  • IMKTA has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 12.90% of the earnings are spent on dividend by IMKTA. This is a low number and sustainable payout ratio.
DP12.9%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (2/27/2026, 8:11:05 PM)

After market: 85.106 +0.01 (+0.01%)

85.1

+0.48 (+0.57%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners95.58%
Inst Owner Change-1.01%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.62B
Revenue(TTM)5.42B
Net Income(TTM)95.13M
Analysts84.44
Price TargetN/A
Short Float %6.54%
Short Ratio7.63
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP12.9%
Div Incr Years0
Div Non Decr Years11
Ex-Date01-08
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.99
Fwd PE N/A
P/S 0.3
P/FCF 13.13
P/OCF 6.84
P/B 0.99
P/tB 0.99
EV/EBITDA 6.87
EPS(TTM)5.01
EY5.89%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.48
FCFY7.62%
OCF(TTM)12.44
OCFY14.61%
SpS285.36
BVpS86.39
TBVpS86.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number98.68
Profitability
Industry RankSector Rank
ROA 3.7%
ROE 5.8%
ROCE 5.87%
ROIC 4.46%
ROICexc 5.3%
ROICexgc 5.3%
OM 2.47%
PM (TTM) 1.76%
GM 24.13%
FCFM 2.27%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
F-Score7
Asset Turnover2.11
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.17
Debt/EBITDA 1.93
Cap/Depr 92.5%
Cap/Sales 2.09%
Interest Coverage 250
Cash Conversion 92.19%
Profit Quality 129.37%
Current Ratio 3.36
Quick Ratio 1.69
Altman-Z 4.53
F-Score7
WACC8.23%
ROIC/WACC0.54
Cap/Depr(3y)138.74%
Cap/Depr(5y)127.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.75%
Profit Quality(3y)46.78%
Profit Quality(5y)57.46%
High Growth Momentum
Growth
EPS 1Y (TTM)20.98%
EPS 3Y-32.58%
EPS 5Y-12.98%
EPS Q2Q%70.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.51%
Revenue growth 3Y-2.07%
Revenue growth 5Y2.96%
Sales Q2Q%6.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.36%
EBIT growth 3Y-32.56%
EBIT growth 5Y-16.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y160.56%
FCF growth 3Y-43.53%
FCF growth 5Y-29.5%
OCF growth 1Y5.1%
OCF growth 3Y-23.15%
OCF growth 5Y-15.14%

INGLES MARKETS INC-CLASS A / IMKTA FAQ

What is the fundamental rating for IMKTA stock?

ChartMill assigns a fundamental rating of 4 / 10 to IMKTA.


What is the valuation status for IMKTA stock?

ChartMill assigns a valuation rating of 4 / 10 to INGLES MARKETS INC-CLASS A (IMKTA). This can be considered as Fairly Valued.


How profitable is INGLES MARKETS INC-CLASS A (IMKTA) stock?

INGLES MARKETS INC-CLASS A (IMKTA) has a profitability rating of 3 / 10.


What is the valuation of INGLES MARKETS INC-CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INGLES MARKETS INC-CLASS A (IMKTA) is 16.99 and the Price/Book (PB) ratio is 0.99.


How financially healthy is INGLES MARKETS INC-CLASS A?

The financial health rating of INGLES MARKETS INC-CLASS A (IMKTA) is 7 / 10.